Philip A Ades1, Patrick D Savage2, Stefan Lischke2, Michael J Toth2, Jean Harvey-Berino3, Janice Y Bunn4, Maryann Ludlow3, David J Schneider2. 1. Department of Medicine, Division of Cardiology, Cardiac Rehabilitation and Prevention, University of Vermont College of Medicine, South Burlington, VT. Electronic address: Philip.Ades@vtmednet.org. 2. Department of Medicine, Division of Cardiology, Cardiac Rehabilitation and Prevention, University of Vermont College of Medicine, South Burlington, VT. 3. Department of Nutrition, Division of Cardiology, Cardiac Rehabilitation and Prevention, University of Vermont College of Medicine, South Burlington, VT. 4. Department of Biostatistics, Division of Cardiology, Cardiac Rehabilitation and Prevention, University of Vermont College of Medicine, South Burlington, VT.
Abstract
BACKGROUND: More than 80% of patients entering cardiac rehabilitation are overweight, with a high prevalence of associated insulin resistance, diabetes, hypertension, hyperlipidemia, and a prothrombotic state. Because each of these characteristics is associated with abnormalities of endothelial-dependent flow-mediated dilatation (FMD), a predictor of long-term prognosis in patients with coronary heart disease (CHD), we assessed the effect of exercise training and weight reduction on FMD in overweight patients with CHD. METHODS: All patients (N = 38) participated in behavioral weight loss while taking their usual preventive medications. Subjects were randomized to one of two exercise protocols, which differed by caloric expenditure. The primary outcome was extent (%) of brachial artery FMD measured by ultrasonography before and after the 4-month exercise and weight-loss program. RESULTS: Both study groups experienced an increase in brachial artery FMD after weight loss and exercise. Patients randomized to the higher-caloric exercise condition (longer-distance walking) lost more weight (8.6 ± 4.1 kg vs 2.3 ± 3.3 kg [P < .001]) and experienced a greater percentage increase in brachial artery FMD (3.6% ± 4.1% vs 1.3% ± 2.1%, P < .05) than did subjects in the lower-caloric-expenditure exercise group who lost less weight. Both groups increased peak aerobic capacity similarly. Increased FMD correlated with changes in body weight more than with measures of abdominal fat, glucose disposal, lipid measure, BP, or measures of physical activity or cardiorespiratory fitness. CONCLUSIONS: Exercise and weight loss increased FMD in overweight and obese patients with CHD. Greater weight reduction was associated with a greater improvement in FMD; thus, there was a dose effect. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00628277; URL: www.clinicaltrials.gov.
RCT Entities:
BACKGROUND: More than 80% of patients entering cardiac rehabilitation are overweight, with a high prevalence of associated insulin resistance, diabetes, hypertension, hyperlipidemia, and a prothrombotic state. Because each of these characteristics is associated with abnormalities of endothelial-dependent flow-mediated dilatation (FMD), a predictor of long-term prognosis in patients with coronary heart disease (CHD), we assessed the effect of exercise training and weight reduction on FMD in overweight patients with CHD. METHODS: All patients (N = 38) participated in behavioral weight loss while taking their usual preventive medications. Subjects were randomized to one of two exercise protocols, which differed by caloric expenditure. The primary outcome was extent (%) of brachial artery FMD measured by ultrasonography before and after the 4-month exercise and weight-loss program. RESULTS: Both study groups experienced an increase in brachial artery FMD after weight loss and exercise. Patients randomized to the higher-caloric exercise condition (longer-distance walking) lost more weight (8.6 ± 4.1 kg vs 2.3 ± 3.3 kg [P < .001]) and experienced a greater percentage increase in brachial artery FMD (3.6% ± 4.1% vs 1.3% ± 2.1%, P < .05) than did subjects in the lower-caloric-expenditure exercise group who lost less weight. Both groups increased peak aerobic capacity similarly. Increased FMD correlated with changes in body weight more than with measures of abdominal fat, glucose disposal, lipid measure, BP, or measures of physical activity or cardiorespiratory fitness. CONCLUSIONS: Exercise and weight loss increased FMD in overweight and obesepatients with CHD. Greater weight reduction was associated with a greater improvement in FMD; thus, there was a dose effect. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00628277; URL: www.clinicaltrials.gov.
Authors: Philip A Ades; Patrick D Savage; Clinton A Brawner; Caroline E Lyon; Jonathan K Ehrman; Janice Y Bunn; Steven J Keteyian Journal: Circulation Date: 2006-06-05 Impact factor: 29.690
Authors: Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert Journal: Circulation Date: 2006-05-16 Impact factor: 29.690
Authors: Michael J Toth; Brian C Cooper; Richard E Pratley; Andrea Mari; Dwight E Matthews; Peter R Casson Journal: Am J Physiol Endocrinol Metab Date: 2008-04-15 Impact factor: 4.310
Authors: Tim H A Schreuder; Daniel J Green; Jean Nyakayiru; Maria T E Hopman; Dick H J Thijssen Journal: Eur J Appl Physiol Date: 2014-09-27 Impact factor: 3.078
Authors: Binu P Thomas; Uma S Yezhuvath; Benjamin Y Tseng; Peiying Liu; Benjamin D Levine; Rong Zhang; Hanzhang Lu Journal: J Magn Reson Imaging Date: 2013-03-22 Impact factor: 4.813
Authors: D Walter Wray; Melissa A H Witman; Stephen J Ives; John McDaniel; Joel D Trinity; Jamie D Conklin; Mark A Supiano; Russell S Richardson Journal: Hypertension Date: 2013-06-17 Impact factor: 10.190
Authors: Henry Blomster; Tomi Laitinen; Tiina Lyyra-Laitinen; Esko Vanninen; Helena Gylling; Markku Peltonen; Tarja Martikainen; Johanna Sahlman; Jouko Kokkarinen; Jukka Randell; Grigori Smirnov; Juha Seppä; Henri Tuomilehto Journal: Sleep Breath Date: 2013-06-04 Impact factor: 2.816
Authors: In Hyun Jung; Jongkwon Seo; Gwang Sil Kim; Hye Young Lee; Young Sup Byun; Byung Ok Kim; Kun Joo Rhee; Sung-Jin Hong; Chul Kim Journal: Cardiovasc J Afr Date: 2021-06-08 Impact factor: 1.167